Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 18, 2020
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
[ Tue, Feb 18th 2020
] - WOPRAI
Ziyi Chen Initiated (BGNE) at Strong Buy and Held Target at $197 on, Feb 18th, 2020
Ziyi Chen of Goldman Sachs, Initiated "BeiGene, Ltd." (BGNE) at Strong Buy and Held Target at $197 on, Feb 18th, 2020.
Ziyi has made no other calls on BGNE in the last 4 months.
There are 3 other peers that have a rating on BGNE. Out of the 3 peers that are also analyzing BGNE, 1 agrees with Ziyi's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tyler Van Buren of "Piper Sandler" Downgraded from Buy to Hold on, Monday, December 16th, 2019
These are the ratings of the 2 analyists that currently disagree with Ziyi
- Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $210 on, Friday, January 17th, 2020
- Yaron Werber of "Cowen & Co." Maintained at Buy with Increased Target to $225 on, Wednesday, November 13th, 2019
